A Phase 2, Multicenter, Randomized, Placebo-Controlled, Double-blind Study in Patients With Acquired Thrombotic Thrombocytopenic Purpura (aTTP) to Evaluate the Pharmacokinetics, Safety and Efficacy of rADAMTS-13 (SHP655) Administered in Addition to Standard Of Care (SoC) Treatment
收藏DataCite Commons2025-09-18 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/PR00011785/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of this study is to evaluate the pharmacokinetics, safety, and efficacy of rADAMTS-13 (SHP655) administered in addition to standard of care (SoC) treatment of acquired thrombotic thrombocytopenic purpura (aTTP) participants.
提供机构：
Vivli
创建时间：
2025-09-16
